Skip to main content
Signal8

Violin Jonathan

SEC insider (Form 3/4/5 filer). CIK 0001730615. Director at Korsana Biosciences, Inc. (KRSA) and 3 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 2, 2026. Located in WALTHAM, MA.

Companies Violin Jonathan has filed insider reports for

  • Korsana Biosciences, Inc. (KRSA): Director, Officer, See Remarks
  • CRESCENT BIOPHARMA, INC. (CBIO): Director
  • Dianthus Therapeutics, Inc. /DE/ (DNTH): Director
  • Astria Therapeutics, Inc. (ATXS): Director
Violin Jonathan profile photo

Violin Jonathan

CIK: 0001730615

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

Korsana Biosciences, Inc. logo
KRSA

Korsana Biosciences, Inc.

DirectorOfficer
CRESCENT BIOPHARMA, INC. logo
CBIO

CRESCENT BIOPHARMA, INC.

Director
Dianthus Therapeutics, Inc. /DE/ logo
DNTH

Dianthus Therapeutics, Inc. /DE/

Director
Astria Therapeutics, Inc. logo
ATXS

Astria Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • CRESCENT BIOPHARMA, INC. logo
    CBIO

    CRESCENT BIOPHARMA, INC.

    Jun 2, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    11.1K shares-
  • Dianthus Therapeutics, Inc. /DE/ logo
    DNTH

    Dianthus Therapeutics, Inc. /DE/

    May 21, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    6.1K shares-
  • Astria Therapeutics, Inc. logo
    ATXS

    Astria Therapeutics, Inc.

    Jan 23, 2026
    Disposition
    Direct
    263.3K shares-
  • GLYCOMIMETICS INC logo
    CBIO

    GLYCOMIMETICS INC

    Jun 23, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    9K shares-
  • Astria Therapeutics, Inc. logo
    ATXS

    Astria Therapeutics, Inc.

    Jun 11, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    26.6K shares-
  • Dianthus Therapeutics, Inc. /DE/ logo
    DNTH

    Dianthus Therapeutics, Inc. /DE/

    May 22, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    12.5K shares-

1-6 of 6